Titan Medical Inc
TSX:TMD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.045
1.125
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Titan Medical Inc
Titan Medical Inc
Capital Expenditures
Titan Medical Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Titan Medical Inc
TSX:TMD
|
Capital Expenditures
-$116k
|
CAGR 3-Years
48%
|
CAGR 5-Years
25%
|
CAGR 10-Years
-4%
|
|
|
Profound Medical Corp
TSX:PRN
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Opsens Inc
TSX:OPS
|
Capital Expenditures
-CA$2.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-17%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Capital Expenditures
-CA$4.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Capital Expenditures
-CA$26.8k
|
CAGR 3-Years
48%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-10%
|
|
|
MedMira Inc
XTSX:MIR
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Titan Medical Inc
Glance View
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.
See Also
What is Titan Medical Inc's Capital Expenditures?
Capital Expenditures
-116k
USD
Based on the financial report for Jun 30, 2024, Titan Medical Inc's Capital Expenditures amounts to -116k USD.
What is Titan Medical Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-4%
Over the last year, the Capital Expenditures growth was 82%. The average annual Capital Expenditures growth rates for Titan Medical Inc have been 48% over the past three years , 25% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
